RAYLEE BABER: Open Payments
NPI 1235899683 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 73 payments from 16 companies in 2025. Trend: 2023 $3,246 · 2024 $2,850 · 2025 $1,859
Food & beverage: $1,490Education: $369
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $306 |
| Galderma Laboratories, L.P. | 10 | $242 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $214 |
| UCB, Inc. | 10 | $213 |
| ABBVIE INC. | 14 | $185 |
| Janssen Biotech, Inc. | 3 | $137 |
| Organon LLC | 5 | $126 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| PFIZER INC. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, TREMFYA, RINVOQ, SKYRIZI, CIBINQO, OTEZLA.
Industry payments across TX — which companies pay providers there.
